Search research articles
Contact Us
Filters
Showing results (41-50 of 250) with videos related to
Page
of 25
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)
|
March 18, 2010
Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients
A Jayaprakash Patil, Ashish Sharma, M Cristina Kenney, et al.
Journal of Vitreoretinal Diseases
|
November 17, 2023
Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases
Ashish Sharma, Anat Loewenstein, Nikulaa Parachuri, et al.
Indian Journal of Ophthalmology
|
June 1, 2022
Supplemental nutrition for retinal health: Evidence based analysis of commercial preparations in India
Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, et al.
The British Journal of Ophthalmology
|
July 19, 2019
Understanding biosimilars and its regulatory aspects across the globe: an ophthalmology perspective
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Eye (London, England)
|
November 8, 2019
Faricimab: expanding horizon beyond VEGF
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Eye (London, England)
|
October 18, 2019
Ophthalmic biosimilars and biologics-role of endotoxins
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Eye (London, England)
|
April 11, 2019
Biotherapeutics and immunogenicity: ophthalmic perspective
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Retina (Philadelphia, Pa.)
|
February 28, 2012
Sutureless 23-gauge versus 20-gauge vitrectomy with silicone oil injection in rhegmatogenous retinal detachment
Raja Narayanan, Nandkishore Tibra, Annie Mathai, et al.
Indian Journal of Ophthalmology
|
July 24, 2019
Ophthalmic biosimilars: Lessons from India
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Eye (London, England)
|
September 19, 2019
Brolucizumab: is extended VEGF suppression on the horizon?
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Page
of 25
Search research articles
Search
Showing results (41-50 of 250) with videos related to
Sort By:
Page
of 25
Clinical Ophthalmology (Auckland, N.Z.)
|
March 18, 2010
Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients
A Jayaprakash Patil, Ashish Sharma, M Cristina Kenney, et al.
Journal of Vitreoretinal Diseases
|
November 17, 2023
Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases
Ashish Sharma, Anat Loewenstein, Nikulaa Parachuri, et al.
Indian Journal of Ophthalmology
|
June 1, 2022
Supplemental nutrition for retinal health: Evidence based analysis of commercial preparations in India
Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, et al.
The British Journal of Ophthalmology
|
July 19, 2019
Understanding biosimilars and its regulatory aspects across the globe: an ophthalmology perspective
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Eye (London, England)
|
November 8, 2019
Faricimab: expanding horizon beyond VEGF
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Eye (London, England)
|
October 18, 2019
Ophthalmic biosimilars and biologics-role of endotoxins
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Eye (London, England)
|
April 11, 2019
Biotherapeutics and immunogenicity: ophthalmic perspective
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Retina (Philadelphia, Pa.)
|
February 28, 2012
Sutureless 23-gauge versus 20-gauge vitrectomy with silicone oil injection in rhegmatogenous retinal detachment
Raja Narayanan, Nandkishore Tibra, Annie Mathai, et al.
Indian Journal of Ophthalmology
|
July 24, 2019
Ophthalmic biosimilars: Lessons from India
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Eye (London, England)
|
September 19, 2019
Brolucizumab: is extended VEGF suppression on the horizon?
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Page
of 25